Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Members of the New Orleans Black Church who believe religion plays an important role in health may eat more fruits and vegetables, be physically active, and be more likely to ask more health questions. .
Read Full NewsPhase 3b study revealed Itvisma's safety and efficacy in treating spinal muscular atrophy, showing modest motor function improvements in patients previously on other therapies.
FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis
Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis
BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development
The HCPFive: Top News for Healthcare Providers from the Week of 12/14
1.
Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.
2.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
3.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.
1.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
2.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
3.
AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Discovering the Benefits of TNK: A Comprehensive Blog Article
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge